Historical record - last NADAC publication: 10/23/2019
Product Information
LAMIVUDINE 150 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.9893 per EA under NDC 50742062360. Its NADAC has been published 114 times since Oct 4, 2017.
Strength
150 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742062360
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
10/23/2019
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA206974On Market Since
2/1/2017
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 150 MG TABLET has been published 114 times since Oct 4, 2017, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9893 per EA |
|---|---|
| All-time high | $1.5942 (Jan 10, 2018) |
| All-time low | $0.7071 (Mar 20, 2019) |
| Median price | $1.1873 |
| Average price | $1.1844 |
| Largest weekly change | +54.1% (May 22, 2019) |
| Weeks tracked | 114 |
| Tracking since | Oct 4, 2017 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.9893 per EA (NDC 50742062360), effective Dec 4, 2019.
How has the price of LAMIVUDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 32.4%. It has been tracked across 114 weekly CMS publications since Oct 4, 2017.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?
Since Oct 4, 2017, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.7071 (Mar 20, 2019) to a high of $1.5942 (Jan 10, 2018), with a median of $1.1873 per EA.
Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LAMIVUDINE 150 MG TABLET, is $0.4602 per EA — about 53% below LAMIVUDINE 150 MG TABLET.
Who manufactures LAMIVUDINE 150 MG TABLET?
LAMIVUDINE 150 MG TABLET (NDC 50742062360) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification